Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $56.9B |
| FY2017, ended Dec 31, 2017 | $68.0B |
| FY2018, ended Dec 31, 2018 | $53.0B |
| FY2019, ended Dec 31, 2019 | $68.4B |
| FY2020, ended Dec 31, 2020 | $63.2B |
| FY2021, ended Dec 31, 2021 | $83.9B |
| FY2022, ended Dec 31, 2022 | $63.1B |
| FY2023, ended Dec 31, 2023 | $61.6B |
| FY2024, ended Dec 31, 2024 | $76.3B |
| FY2025, ended Dec 31, 2025 | $84.2B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $98.2B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $15.2B |
| FY2017, ended Dec 31, 2017 | $16.3B |
| FY2018, ended Dec 31, 2018 | $16.2B |
| FY2019, ended Dec 31, 2019 | $16.8B |
| FY2020, ended Dec 31, 2020 | $16.9B |
| FY2021, ended Dec 31, 2021 | $19.2B |
| FY2022, ended Dec 31, 2022 | $21.1B |
| FY2023, ended Dec 31, 2023 | $21.5B |
| FY2024, ended Dec 31, 2024 | $21.6B |
| FY2025, ended Dec 31, 2025 | $23.1B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $25.0B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income |
|---|---|
| FY2016, ended Dec 31, 2016 | $3.66B |
| FY2017, ended Dec 31, 2017 | $5.05B |
| FY2018, ended Dec 31, 2018 | $4.25B |
| FY2019, ended Dec 31, 2019 | $4.28B |
| FY2020, ended Dec 31, 2020 | $2.72B |
| FY2021, ended Dec 31, 2021 | $5.41B |
| FY2022, ended Dec 31, 2022 | $5.71B |
| FY2023, ended Dec 31, 2023 | $5.13B |
| FY2024, ended Dec 31, 2024 | $5.50B |
| FY2025, ended Dec 31, 2025 | $6.58B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $7.27B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $4.88B |
| FY2017, ended Dec 31, 2017 | $5.25B |
| FY2018, ended Dec 31, 2018 | $5.61B |
| FY2019, ended Dec 31, 2019 | $5.06B |
| FY2020, ended Dec 31, 2020 | $7.02B |
| FY2021, ended Dec 31, 2021 | $82.3B |
| FY2022, ended Dec 31, 2022 | $34.4B |
| FY2023, ended Dec 31, 2023 | $50.7B |
| FY2024, ended Dec 31, 2024 | $46.3B |
| FY2025, ended Dec 31, 2025 | $39.7B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $28.7B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | — |
| FY2017, ended Dec 31, 2017 | — |
| FY2018, ended Dec 31, 2018 | — |
| FY2019, ended Dec 31, 2019 | — |
| FY2020, ended Dec 31, 2020 | — |
| FY2021, ended Dec 31, 2021 | — |
| FY2022, ended Dec 31, 2022 | $58.7B |
| FY2023, ended Dec 31, 2023 | $72.7B |
| FY2024, ended Dec 31, 2024 | $61.7B |
| FY2025, ended Dec 31, 2025 | $57.1B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $85.7B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 17.9% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 486M |
| FY2017, ended Dec 31, 2017 | 472M |
| FY2018, ended Dec 31, 2018 | 454M |
| FY2019, ended Dec 31, 2019 | 429M |
| FY2020, ended Dec 31, 2020 | 424M |
| FY2021, ended Dec 31, 2021 | 418M |
| FY2022, ended Dec 31, 2022 | 400M |
| FY2023, ended Dec 31, 2023 | 398M |
| FY2024, ended Dec 31, 2024 | 396M |
| FY2025, ended Dec 31, 2025 | 403M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 399M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $2.06B | $200M |
| FY2017, ended Dec 31, 2017 | $2.45B | $200M |
| FY2018, ended Dec 31, 2018 | $2.88B | — |
| FY2019, ended Dec 31, 2019 | $3.58B | — |
| FY2020, ended Dec 31, 2020 | $1.62B | — |
| FY2021, ended Dec 31, 2021 | $1.08B | — |
| FY2022, ended Dec 31, 2022 | $3.73B | — |
| FY2023, ended Dec 31, 2023 | $651M | — |
| FY2024, ended Dec 31, 2024 | $687M | — |
| FY2025, ended Dec 31, 2025 | $1.34B | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $2.16B | — |
Valuation
At current price- Market Cap
- $90.8B
- P/E
- 12.5×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 3.6×
- Price / Book
- 1.4×
- EV / EBITDA
- —. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $25.0B
- Revenue Growth YoY
- 13.2%
- Revenue CAGR 3Y
- 3.0%
- Revenue CAGR 5Y
- 6.4%
- EPS Growth YoY
- 24.1%
- Net Income Growth YoY
- 21.0%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- —
- Net Margin
- 29.0%
- FCF Margin
- —. Free cash flow / revenue
- Return on Equity
- 12.0%
Earnings
Trailing 12 months- Net Income
- $7.27B
- EPS (diluted)
- $18.16
- EBITDA
- —. Operating income + depreciation & amortization
- Operating Income
- —
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $28.7B
- Total Debt
- $85.7B
- Net Debt
- $57.0B
- Total Assets
- $616B
- Total Liabilities
- $552B
- Shareholders' Equity
- $64.0B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $7.49B
- Capital Expenditure
- —
- Free Cash Flow
- —. Operating cash flow − capital expenditure
Dividends and risk
Last 12 months- Dividend Yield
- 3.3%
- Dividend / Share
- $7.40
- Beta (5Y)
- 0.94
Every ratio is calculated from the company’s reported figures.